Identification of Biomarkers Associated with Cancerous Change in Oral Leukoplakia Based on Integrated Transcriptome Analysis

Figure 6

The three-dimensional view of the docking of selumetinib and DCT (a). Two-dimensional plan view of the docking of selumetinib and DCT (b). The three-dimensional view of the docking of selumetinib and KRT3 (c). Two-dimensional plan view of the docking of selumetinib and KRT3 (d). The three-dimensional view of the docking of selumetinib and KRT76 (e). Two-dimensional plan view of the docking of selumetinib and KRT76 (f). The three-dimensional view of the docking of selumetinib and FAM3B (g). Two-dimensional plan view of the docking of selumetinib and FAM3B (h). Three-dimensional view of the docking of benidipine with DCT (i). Two-dimensional plan view of the docking of benidipine with DCT (j). The three-dimensional view of the docking of benidipine and KRT3 (k). Two-dimensional plan view of the docking of benidipine and KRT3 (l). The three-dimensional view of the docking of benidipine and KRT76 (m). Two-dimensional plan view of the docking of benidipine and KRT76 (n). Three-dimensional view of the docking of benidipine and FAM3B (o). Two-dimensional plan view of the docking of benidipine and FAM3B (p).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)